Skip to main content
. 2019 Sep 16;9:13384. doi: 10.1038/s41598-019-49786-7

Figure 2.

Figure 2

Rab1A expression correlated with TNM stage and mTOR targets in gastrointestinal cancers. (A) Rab1A expression in different TNM stages in esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), liver hepatocellular carcinoma (LIHC), cholangio carcinoma (CHOL) and pancreatic adenocarcinoma (PAAD). (B) Correlation analysis between Rab1A and upstream/downstream mTOR targets in the above cancers.